LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Editorial

Implementing fixed dose combination medications for the prevention and control of cardiovascular diseases

Webster R, Murphy A, Bygrave H, Ansbro É, Grobbee DE, Perel P
Download
Download
Abstract
HIGHLIGHTS
-- Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor.
-- A symposium was held bringing together stakeholders on this issue, including from academia, government and NGOs.
-- The conclusion made was that what is now needed to improve implementation of FDCs is country-specific health systems analyses to design appropriate implementation strategies.
-- Implementation strategies must look beyond listing on the WHO Essential Medicines List to consider approaches to improving FDC availability, accessibility, affordability, and adherence.
-- Strategies might include incorporation of FDCs into the WHO HEARTS technical package, simplified treatment and monitoring algorithms, decentralisation of medicine dispensing and task-sharing for treatment management.
Subject Area
non-communicable diseasecardiovascular disease
DOI
10.5334/gh.860
Published Date
31-Dec-2019
PubMed ID
32923350
Languages
English
Journal
Global Heart
Volume / Issue / Pages
Volume 15, Issue 1, Pages 57
Issue Date
01-Jan-2020
Dimensions Badge